Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016

No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Ins...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology oncology research 2021-04, Vol.27, p.598862-598862
Hauptverfasser: Tamási, Lilla, Horváth, Krisztián, Kiss, Zoltán, Bogos, Krisztina, Ostoros, Gyula, Müller, Veronika, Urbán, László, Bittner, Nóra, Sárosi, Veronika, Vastag, Aladár, Polányi, Zoltán, Nagy-Erdei, Zsófia, Daniel, Andrea, Nagy, Balázs, Rokszin, György, Abonyi-Tóth, Zsolt, Moldvay, Judit, Vokó, Zoltán, Gálffy, Gabriella
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 598862
container_issue
container_start_page 598862
container_title Pathology oncology research
container_volume 27
creator Tamási, Lilla
Horváth, Krisztián
Kiss, Zoltán
Bogos, Krisztina
Ostoros, Gyula
Müller, Veronika
Urbán, László
Bittner, Nóra
Sárosi, Veronika
Vastag, Aladár
Polányi, Zoltán
Nagy-Erdei, Zsófia
Daniel, Andrea
Nagy, Balázs
Rokszin, György
Abonyi-Tóth, Zsolt
Moldvay, Judit
Vokó, Zoltán
Gálffy, Gabriella
description No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Insurance Fund database. This longitudinal study included patients aged ≥20 years with LC diagnosis (ICD-10 C34) between January 1, 2011 and December 31, 2016. Patients with different cancer-related codes 6 months before or 12 months after LC diagnosis or having any cancer treatment other than lung cancer protocols were excluded. Lung cancer incidence and mortality increased with age, peaking in the 70-79 age group (375.0/100,000 person-years) among males, while at 60-69 age group for females (148.1/100,000 person-years). The male-to-female incidence rate ratio reached 2.46-3.01 ( < 0.0001) among the 70-79 age group. We found 2-11% decrease in male incidence rate at most age groups, while a significant 1-3% increase was observed in older females (>60) annually during the study period. This nationwide epidemiology study demonstrated that LC incidence and mortality in Hungary decreased in younger male and female population, however we found significant increase of incidence in older female population, similar to international trends. Incidence rates peaked in younger age-groups compared to Western countries, most likely due to higher smoking prevalence in these cohorts, while lower age LC incidence could be attributed to higher competing cardiovascular risk resulting in earlier mortality in smoking population.
doi_str_mv 10.3389/pore.2021.598862
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2575515265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-ea965eb245d829524945eea6c57732430862a50390cb40a36985b624e77c701c3</originalsourceid><addsrcrecordid>eNpdkc1vEzEQxS0EoqVw54QsceGSYI8_lwNSFUFbKYgD4Ww53kniamMHexep_z1OU6rCyePxb57m-RHylrO5ELb7eMgF58CAz1VnrYZn5JwrATOwzDx_Up-RV7XeMsaM7vRLciYkKKOUOCd4uUXqU0-vMPVY6I8DhriJgS6ntKULn0Jr3qQQe2zlPfktl9EPcbyjMdHrhvly94muShOodFPyngLjnK52JU_b3fGiX5MXGz9UfPNwXpCfX7-sFtez5ferm8XlchYkyHGGvtMK1yBVb6FTIDupEL0OyhgBUrBm0SsmOhbWknmhO6vWGiQaEwzjQVyQzyfdw7TeYx8wjcUP7lDivi3pso_u35cUd26bfzsLGri1TeDDg0DJvyaso9vHGnAYfMI8VQdKcWWkNrqh7_9Db_NUUrPn7j-XK9CqUexEhZJrLbh5XIYzd8zQHTN0xwzdKcM28u6piceBv6GJP7MwlX8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2575515265</pqid></control><display><type>article</type><title>Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><source>PubMed Central Open Access</source><creator>Tamási, Lilla ; Horváth, Krisztián ; Kiss, Zoltán ; Bogos, Krisztina ; Ostoros, Gyula ; Müller, Veronika ; Urbán, László ; Bittner, Nóra ; Sárosi, Veronika ; Vastag, Aladár ; Polányi, Zoltán ; Nagy-Erdei, Zsófia ; Daniel, Andrea ; Nagy, Balázs ; Rokszin, György ; Abonyi-Tóth, Zsolt ; Moldvay, Judit ; Vokó, Zoltán ; Gálffy, Gabriella</creator><creatorcontrib>Tamási, Lilla ; Horváth, Krisztián ; Kiss, Zoltán ; Bogos, Krisztina ; Ostoros, Gyula ; Müller, Veronika ; Urbán, László ; Bittner, Nóra ; Sárosi, Veronika ; Vastag, Aladár ; Polányi, Zoltán ; Nagy-Erdei, Zsófia ; Daniel, Andrea ; Nagy, Balázs ; Rokszin, György ; Abonyi-Tóth, Zsolt ; Moldvay, Judit ; Vokó, Zoltán ; Gálffy, Gabriella</creatorcontrib><description>No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Insurance Fund database. This longitudinal study included patients aged ≥20 years with LC diagnosis (ICD-10 C34) between January 1, 2011 and December 31, 2016. Patients with different cancer-related codes 6 months before or 12 months after LC diagnosis or having any cancer treatment other than lung cancer protocols were excluded. Lung cancer incidence and mortality increased with age, peaking in the 70-79 age group (375.0/100,000 person-years) among males, while at 60-69 age group for females (148.1/100,000 person-years). The male-to-female incidence rate ratio reached 2.46-3.01 ( &lt; 0.0001) among the 70-79 age group. We found 2-11% decrease in male incidence rate at most age groups, while a significant 1-3% increase was observed in older females (&gt;60) annually during the study period. This nationwide epidemiology study demonstrated that LC incidence and mortality in Hungary decreased in younger male and female population, however we found significant increase of incidence in older female population, similar to international trends. Incidence rates peaked in younger age-groups compared to Western countries, most likely due to higher smoking prevalence in these cohorts, while lower age LC incidence could be attributed to higher competing cardiovascular risk resulting in earlier mortality in smoking population.</description><identifier>ISSN: 1532-2807</identifier><identifier>ISSN: 1219-4956</identifier><identifier>EISSN: 1532-2807</identifier><identifier>DOI: 10.3389/pore.2021.598862</identifier><identifier>PMID: 34257553</identifier><language>eng</language><publisher>Switzerland: Frontiers Media SA</publisher><subject>Adult ; Age Factors ; Age groups ; Aged ; Aged, 80 and over ; Annual reports ; Databases, Factual ; Epidemiology ; Female ; Females ; Follow-Up Studies ; Gender ; Humans ; Hungary - epidemiology ; Incidence ; Longitudinal Studies ; Lung cancer ; Lung Neoplasms - epidemiology ; Lung Neoplasms - mortality ; Male ; Males ; Medical research ; Middle Aged ; Mortality ; Mortality - trends ; Patients ; Prognosis ; Retrospective Studies ; Sex Factors ; Society Journal Archive ; Survival Rate ; Time Factors ; Trends ; Web portals ; Womens health ; Young Adult</subject><ispartof>Pathology oncology research, 2021-04, Vol.27, p.598862-598862</ispartof><rights>Copyright © 2021 Tamási, Horváth, Kiss, Bogos, Ostoros, Müller, Urbán, Bittner, Sárosi, Vastag, Polányi, Nagy-Erdei, Daniel, Nagy, Rokszin, Abonyi-Tóth, Moldvay, Vokó and Gálffy.</rights><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2021 Tamási, Horváth, Kiss, Bogos, Ostoros, Müller, Urbán, Bittner, Sárosi, Vastag, Polányi, Nagy-Erdei, Daniel, Nagy, Rokszin, Abonyi-Tóth, Moldvay, Vokó and Gálffy. 2021 Tamási, Horváth, Kiss, Bogos, Ostoros, Müller, Urbán, Bittner, Sárosi, Vastag, Polányi, Nagy-Erdei, Daniel, Nagy, Rokszin, Abonyi-Tóth, Moldvay, Vokó and Gálffy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-ea965eb245d829524945eea6c57732430862a50390cb40a36985b624e77c701c3</citedby><cites>FETCH-LOGICAL-c424t-ea965eb245d829524945eea6c57732430862a50390cb40a36985b624e77c701c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262188/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262188/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27915,27916,53782,53784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34257553$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tamási, Lilla</creatorcontrib><creatorcontrib>Horváth, Krisztián</creatorcontrib><creatorcontrib>Kiss, Zoltán</creatorcontrib><creatorcontrib>Bogos, Krisztina</creatorcontrib><creatorcontrib>Ostoros, Gyula</creatorcontrib><creatorcontrib>Müller, Veronika</creatorcontrib><creatorcontrib>Urbán, László</creatorcontrib><creatorcontrib>Bittner, Nóra</creatorcontrib><creatorcontrib>Sárosi, Veronika</creatorcontrib><creatorcontrib>Vastag, Aladár</creatorcontrib><creatorcontrib>Polányi, Zoltán</creatorcontrib><creatorcontrib>Nagy-Erdei, Zsófia</creatorcontrib><creatorcontrib>Daniel, Andrea</creatorcontrib><creatorcontrib>Nagy, Balázs</creatorcontrib><creatorcontrib>Rokszin, György</creatorcontrib><creatorcontrib>Abonyi-Tóth, Zsolt</creatorcontrib><creatorcontrib>Moldvay, Judit</creatorcontrib><creatorcontrib>Vokó, Zoltán</creatorcontrib><creatorcontrib>Gálffy, Gabriella</creatorcontrib><title>Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016</title><title>Pathology oncology research</title><addtitle>Pathol Oncol Res</addtitle><description>No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Insurance Fund database. This longitudinal study included patients aged ≥20 years with LC diagnosis (ICD-10 C34) between January 1, 2011 and December 31, 2016. Patients with different cancer-related codes 6 months before or 12 months after LC diagnosis or having any cancer treatment other than lung cancer protocols were excluded. Lung cancer incidence and mortality increased with age, peaking in the 70-79 age group (375.0/100,000 person-years) among males, while at 60-69 age group for females (148.1/100,000 person-years). The male-to-female incidence rate ratio reached 2.46-3.01 ( &lt; 0.0001) among the 70-79 age group. We found 2-11% decrease in male incidence rate at most age groups, while a significant 1-3% increase was observed in older females (&gt;60) annually during the study period. This nationwide epidemiology study demonstrated that LC incidence and mortality in Hungary decreased in younger male and female population, however we found significant increase of incidence in older female population, similar to international trends. Incidence rates peaked in younger age-groups compared to Western countries, most likely due to higher smoking prevalence in these cohorts, while lower age LC incidence could be attributed to higher competing cardiovascular risk resulting in earlier mortality in smoking population.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Age groups</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Annual reports</subject><subject>Databases, Factual</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Females</subject><subject>Follow-Up Studies</subject><subject>Gender</subject><subject>Humans</subject><subject>Hungary - epidemiology</subject><subject>Incidence</subject><subject>Longitudinal Studies</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Lung Neoplasms - mortality</subject><subject>Male</subject><subject>Males</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mortality - trends</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Sex Factors</subject><subject>Society Journal Archive</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Trends</subject><subject>Web portals</subject><subject>Womens health</subject><subject>Young Adult</subject><issn>1532-2807</issn><issn>1219-4956</issn><issn>1532-2807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkc1vEzEQxS0EoqVw54QsceGSYI8_lwNSFUFbKYgD4Ww53kniamMHexep_z1OU6rCyePxb57m-RHylrO5ELb7eMgF58CAz1VnrYZn5JwrATOwzDx_Up-RV7XeMsaM7vRLciYkKKOUOCd4uUXqU0-vMPVY6I8DhriJgS6ntKULn0Jr3qQQe2zlPfktl9EPcbyjMdHrhvly94muShOodFPyngLjnK52JU_b3fGiX5MXGz9UfPNwXpCfX7-sFtez5ferm8XlchYkyHGGvtMK1yBVb6FTIDupEL0OyhgBUrBm0SsmOhbWknmhO6vWGiQaEwzjQVyQzyfdw7TeYx8wjcUP7lDivi3pso_u35cUd26bfzsLGri1TeDDg0DJvyaso9vHGnAYfMI8VQdKcWWkNrqh7_9Db_NUUrPn7j-XK9CqUexEhZJrLbh5XIYzd8zQHTN0xwzdKcM28u6piceBv6GJP7MwlX8</recordid><startdate>20210430</startdate><enddate>20210430</enddate><creator>Tamási, Lilla</creator><creator>Horváth, Krisztián</creator><creator>Kiss, Zoltán</creator><creator>Bogos, Krisztina</creator><creator>Ostoros, Gyula</creator><creator>Müller, Veronika</creator><creator>Urbán, László</creator><creator>Bittner, Nóra</creator><creator>Sárosi, Veronika</creator><creator>Vastag, Aladár</creator><creator>Polányi, Zoltán</creator><creator>Nagy-Erdei, Zsófia</creator><creator>Daniel, Andrea</creator><creator>Nagy, Balázs</creator><creator>Rokszin, György</creator><creator>Abonyi-Tóth, Zsolt</creator><creator>Moldvay, Judit</creator><creator>Vokó, Zoltán</creator><creator>Gálffy, Gabriella</creator><general>Frontiers Media SA</general><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210430</creationdate><title>Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016</title><author>Tamási, Lilla ; Horváth, Krisztián ; Kiss, Zoltán ; Bogos, Krisztina ; Ostoros, Gyula ; Müller, Veronika ; Urbán, László ; Bittner, Nóra ; Sárosi, Veronika ; Vastag, Aladár ; Polányi, Zoltán ; Nagy-Erdei, Zsófia ; Daniel, Andrea ; Nagy, Balázs ; Rokszin, György ; Abonyi-Tóth, Zsolt ; Moldvay, Judit ; Vokó, Zoltán ; Gálffy, Gabriella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-ea965eb245d829524945eea6c57732430862a50390cb40a36985b624e77c701c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Age groups</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Annual reports</topic><topic>Databases, Factual</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Females</topic><topic>Follow-Up Studies</topic><topic>Gender</topic><topic>Humans</topic><topic>Hungary - epidemiology</topic><topic>Incidence</topic><topic>Longitudinal Studies</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Lung Neoplasms - mortality</topic><topic>Male</topic><topic>Males</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mortality - trends</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Sex Factors</topic><topic>Society Journal Archive</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Trends</topic><topic>Web portals</topic><topic>Womens health</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tamási, Lilla</creatorcontrib><creatorcontrib>Horváth, Krisztián</creatorcontrib><creatorcontrib>Kiss, Zoltán</creatorcontrib><creatorcontrib>Bogos, Krisztina</creatorcontrib><creatorcontrib>Ostoros, Gyula</creatorcontrib><creatorcontrib>Müller, Veronika</creatorcontrib><creatorcontrib>Urbán, László</creatorcontrib><creatorcontrib>Bittner, Nóra</creatorcontrib><creatorcontrib>Sárosi, Veronika</creatorcontrib><creatorcontrib>Vastag, Aladár</creatorcontrib><creatorcontrib>Polányi, Zoltán</creatorcontrib><creatorcontrib>Nagy-Erdei, Zsófia</creatorcontrib><creatorcontrib>Daniel, Andrea</creatorcontrib><creatorcontrib>Nagy, Balázs</creatorcontrib><creatorcontrib>Rokszin, György</creatorcontrib><creatorcontrib>Abonyi-Tóth, Zsolt</creatorcontrib><creatorcontrib>Moldvay, Judit</creatorcontrib><creatorcontrib>Vokó, Zoltán</creatorcontrib><creatorcontrib>Gálffy, Gabriella</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pathology oncology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tamási, Lilla</au><au>Horváth, Krisztián</au><au>Kiss, Zoltán</au><au>Bogos, Krisztina</au><au>Ostoros, Gyula</au><au>Müller, Veronika</au><au>Urbán, László</au><au>Bittner, Nóra</au><au>Sárosi, Veronika</au><au>Vastag, Aladár</au><au>Polányi, Zoltán</au><au>Nagy-Erdei, Zsófia</au><au>Daniel, Andrea</au><au>Nagy, Balázs</au><au>Rokszin, György</au><au>Abonyi-Tóth, Zsolt</au><au>Moldvay, Judit</au><au>Vokó, Zoltán</au><au>Gálffy, Gabriella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016</atitle><jtitle>Pathology oncology research</jtitle><addtitle>Pathol Oncol Res</addtitle><date>2021-04-30</date><risdate>2021</risdate><volume>27</volume><spage>598862</spage><epage>598862</epage><pages>598862-598862</pages><issn>1532-2807</issn><issn>1219-4956</issn><eissn>1532-2807</eissn><abstract>No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Insurance Fund database. This longitudinal study included patients aged ≥20 years with LC diagnosis (ICD-10 C34) between January 1, 2011 and December 31, 2016. Patients with different cancer-related codes 6 months before or 12 months after LC diagnosis or having any cancer treatment other than lung cancer protocols were excluded. Lung cancer incidence and mortality increased with age, peaking in the 70-79 age group (375.0/100,000 person-years) among males, while at 60-69 age group for females (148.1/100,000 person-years). The male-to-female incidence rate ratio reached 2.46-3.01 ( &lt; 0.0001) among the 70-79 age group. We found 2-11% decrease in male incidence rate at most age groups, while a significant 1-3% increase was observed in older females (&gt;60) annually during the study period. This nationwide epidemiology study demonstrated that LC incidence and mortality in Hungary decreased in younger male and female population, however we found significant increase of incidence in older female population, similar to international trends. Incidence rates peaked in younger age-groups compared to Western countries, most likely due to higher smoking prevalence in these cohorts, while lower age LC incidence could be attributed to higher competing cardiovascular risk resulting in earlier mortality in smoking population.</abstract><cop>Switzerland</cop><pub>Frontiers Media SA</pub><pmid>34257553</pmid><doi>10.3389/pore.2021.598862</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1532-2807
ispartof Pathology oncology research, 2021-04, Vol.27, p.598862-598862
issn 1532-2807
1219-4956
1532-2807
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262188
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; EZB Electronic Journals Library; PubMed Central Open Access
subjects Adult
Age Factors
Age groups
Aged
Aged, 80 and over
Annual reports
Databases, Factual
Epidemiology
Female
Females
Follow-Up Studies
Gender
Humans
Hungary - epidemiology
Incidence
Longitudinal Studies
Lung cancer
Lung Neoplasms - epidemiology
Lung Neoplasms - mortality
Male
Males
Medical research
Middle Aged
Mortality
Mortality - trends
Patients
Prognosis
Retrospective Studies
Sex Factors
Society Journal Archive
Survival Rate
Time Factors
Trends
Web portals
Womens health
Young Adult
title Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T17%3A26%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age%20and%20Gender%20Specific%20Lung%20Cancer%20Incidence%20and%20Mortality%20in%20Hungary:%20Trends%20from%202011%20Through%202016&rft.jtitle=Pathology%20oncology%20research&rft.au=Tam%C3%A1si,%20Lilla&rft.date=2021-04-30&rft.volume=27&rft.spage=598862&rft.epage=598862&rft.pages=598862-598862&rft.issn=1532-2807&rft.eissn=1532-2807&rft_id=info:doi/10.3389/pore.2021.598862&rft_dat=%3Cproquest_pubme%3E2575515265%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2575515265&rft_id=info:pmid/34257553&rfr_iscdi=true